title: Dependence of regenerated sensory axons on continuous neurotrophin-3 delivery.
abstract: Previous studies have shown that injured dorsal column sensory axons extend across a spinal cord lesion site if axons are guided by a gradient of neurotrophin-3 (NT-3) rostral to the lesion. Here we examined whether continuous NT-3 delivery is necessary to sustain regenerated axons in the injured spinal cord. Using tetracycline-regulated (tet-off) lentiviral gene delivery, NT-3 expression was tightly controlled by doxycycline administration. To examine axon growth responses to regulated NT-3 expression, adult rats underwent a C3 dorsal funiculus lesion. The lesion site was filled with bone marrow stromal cells, tet-off-NT-3 virus was injected rostral to the lesion site, and the intrinsic growth capacity of sensory neurons was activated by a conditioning lesion. When NT-3 gene expression was turned on, cholera toxin β-subunit-labeled sensory axons regenerated into and beyond the lesion/graft site. Surprisingly, the number of regenerated axons significantly declined when NT-3 expression was turned off, whereas continued NT-3 expression sustained regenerated axons. Quantification of axon numbers beyond the lesion demonstrated a significant decline of axon growth in animals with transient NT-3 expression, only some axons that had regenerated over longer distance were sustained. Regenerated axons were located in white matter and did not form axodendritic synapses but expressed presynaptic markers when closely associated with NG2-labeled cells. A decline in axon density was also observed within cellular grafts after NT-3 expression was turned off possibly via reduction in L1 and laminin expression in Schwann cells. Thus, multiple mechanisms underlie the inability of transient NT-3 expression to fully sustain regenerated sensory axons.
authors.affiliation: Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, USA.
authors.forename: Shaoping
authors.initials: S
authors.lastname: Hou
authors.forename: LaShae
authors.initials: L
authors.lastname: Nicholson
authors.forename: Erna
authors.initials: E
authors.lastname: van Niekerk
authors.forename: Melanie
authors.initials: M
authors.lastname: Motsch
authors.forename: Armin
authors.initials: A
authors.lastname: Blesch
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000941:Antigens / Q000378:metabolism; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D017690:Cell Transplantation / Q000379:methods; D002478:Cells, Cultured; D002772:Cholera Toxin; D004195:Disease Models, Animal; D004318:Doxycycline / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D015316:Genetic Therapy / Q000379:methods; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000235:genetics; D057809:HEK293 Cells; D006801:Humans; D007797:Laminin / Q000378:metabolism; D039841:Leukocyte L1 Antigen Complex / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D063308:Myelin-Oligodendrocyte Glycoprotein / Q000378:metabolism; D009414:Nerve Growth Factors / Q000378:metabolism; D009416:Nerve Regeneration / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D016900:Neurofilament Proteins / Q000378:metabolism; D020933:Neurotrophin 3 / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology / Q000627:therapeutic use*; D011509:Proteoglycans / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins / Q000378:metabolism; D012583:Schwann Cells / Q000187:drug effects; D012584:Sciatic Nerve / Q000166:cytology; D011984:Sensory Receptor Cells / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D013119:Spinal Cord Injuries / Q000473:pathology / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods; D013997:Time Factors; D014162:Transfection / Q000379:methods; D000099216:Chondroitin Sulfate Proteoglycan 4
chemical_list: D000941:Antigens; D002772:Cholera Toxin; D004318:Doxycycline; D005904:Glial Fibrillary Acidic Protein; D049452:Green Fluorescent Proteins; D007797:Laminin; D039841:Leukocyte L1 Antigen Complex; D008562:Membrane Glycoproteins; D008869:Microtubule-Associated Proteins; D063308:Myelin-Oligodendrocyte Glycoprotein; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D016900:Neurofilament Proteins; D020933:Neurotrophin 3; D011509:Proteoglycans; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins; D000099216:Chondroitin Sulfate Proteoglycan 4; C489787:MAP2 protein, rat; C489618:Sv2a protein, rat; C051774:neurofilament protein H